UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $4.9M of United Therapeutics Corporation
Sold$4,870,054
$586.75Price
8,300Shares
−16%Stake
What UTHR did after the filing
- The stock from Fri, May 8 open, $569.17
- −4.4%
- S&P 500, same days
- −0.2%
Measured over 30 trading days, to the Jun 23 close.
Traded Thu, May 7. Filed Thu, May 7, 4:31 PM ET, after the close. Returns use the May 8 open and the Jun 23 close. Not investment advice.